Biotechnology
The Biotechnology industry has a total of 592 stocks, with a combined market cap of $1.4 trillion and total revenue of $115.78 billion.
Market Cap
1.4T
Revenue
115.78B
Profits
-39.65B
PE Ratio
n/a
Profit Margin
-34.24%
Dividend Yield
0.04%
592 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 138.72B | -1.01% | 834,203 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 81.36B | -2.25% | 585,177 | 15.53B |
| 3 | ARGX | argenx SE | 65.40B | 2.71% | 361,917 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 59.75B | -5.77% | 21,976,529 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 46.18B | 1.92% | 3,250,074 | - |
| 6 | ONC | BeOne Medicines AG | 42.73B | -0.15% | 125,831 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 35.54B | -0.43% | 1,478,062 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.98B | -0.45% | 1,116,173 | 4.80B |
| 9 | BNTX | BioNTech SE | 28.28B | -1.31% | 1,254,954 | 3.03B |
| 10 | INSM | Insmed Incorporated | 27.16B | 0.40% | 1,979,878 | 1.14B |
| 11 | ROIV | Roivant Sciences Ltd. | 26.55B | 0.77% | 5,260,327 | 7.53M |
| 12 | INCY | Incyte Corporation | 25.97B | -1.23% | 800,046 | 5.82B |
| 13 | GMAB | Genmab A/S | 20.09B | -1.78% | 3,086,693 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 16.43B | -1.08% | 237,263 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 16.18B | -4.20% | 2,418,903 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 15.52B | -1.28% | 1,704,982 | 713.07M |
| 17 | EXEL | Exelixis, Inc. | 13.90B | -1.09% | 1,816,687 | 2.44B |
| 18 | CORT | Corcept Therapeutics Incorporated | 12.95B | -3.05% | 980,620 | 830.81M |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 12.70B | -0.77% | 1,884,297 | 3.41B |
| 20 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.59B | 0.27% | 859,356 | 669.50M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.45B | 5.22% | 345,523 | 1.28B |
| 22 | HALO | Halozyme Therapeutics, Inc. | 12.15B | -2.07% | 1,705,555 | 1.66B |
| 23 | SMMT | Summit Therapeutics Inc. | 11.35B | 6.51% | 10,821,517 | - |
| 24 | TECH | Bio-Techne Corporation | 11.35B | 0.07% | 1,386,236 | 1.22B |
| 25 | CYTK | Cytokinetics, Incorporated | 11.01B | 2.25% | 1,236,590 | 67.67M |
| 26 | ABVX | ABIVAX Société Anonyme | 10.94B | -1.20% | 483,682 | 5.67M |
| 27 | AXSM | Axsome Therapeutics, Inc. | 10.85B | 0.81% | 378,421 | 776.57M |
| 28 | KRYS | Krystal Biotech, Inc. | 10.65B | 1.00% | 246,326 | 440.48M |
| 29 | PRAX | Praxis Precision Medicines, Inc. | 10.54B | 2.54% | 480,488 | 7.46M |
| 30 | IONS | Ionis Pharmaceuticals, Inc. | 10.53B | -0.33% | 2,146,573 | 874.09M |
| 31 | KYMR | Kymera Therapeutics, Inc. | 10.44B | -0.86% | 558,342 | 105.00M |
| 32 | APGE | Apogee Therapeutics, Inc. | 10.18B | 0.07% | 1,613,316 | - |
| 33 | PTGX | Protagonist Therapeutics, Inc. | 9.80B | 0.60% | 335,461 | 281.99M |
| 34 | PCVX | Vaxcyte, Inc. | 9.09B | - | 891,648 | - |
| 35 | IMVT | Immunovant, Inc. | 9.07B | 0.90% | 852,423 | - |
| 36 | CRNX | Crinetics Pharmaceuticals, Inc. | 9.00B | -0.02% | 479,512 | 42.16M |
| 37 | IBRX | ImmunityBio, Inc. | 8.74B | 0.73% | 8,596,781 | 165.79M |
| 38 | SYRE | Spyre Therapeutics, Inc. | 8.25B | -12.81% | 3,114,629 | - |
| 39 | TGTX | TG Therapeutics, Inc. | 7.81B | -0.70% | 963,164 | 799.54M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.70B | -1.31% | 358,951 | 239.92M |
| 41 | CAI | Caris Life Sciences, Inc. | 7.58B | -4.25% | 4,028,229 | 989.61M |
| 42 | SRRK | Scholar Rock Holding Corporation | 7.31B | 3.07% | 2,050,286 | - |
| 43 | CGON | CG Oncology, Inc. | 6.95B | -0.67% | 507,809 | 6.23M |
| 44 | ERAS | Erasca, Inc. | 6.70B | 7.83% | 6,910,763 | - |
| 45 | ORKA | Oruka Therapeutics, Inc. | 6.58B | -2.34% | 526,711 | - |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 6.40B | 0.44% | 571,055 | 618.07M |
| 47 | COGT | Cogent Biosciences, Inc. | 6.37B | -0.22% | 1,062,731 | - |
| 48 | TVTX | Travere Therapeutics, Inc. | 6.33B | 0.16% | 1,215,050 | 591.33M |
| 49 | BLTE | Belite Bio, Inc | 6.31B | -3.09% | 269,759 | - |
| 50 | DNTH | Dianthus Therapeutics, Inc. | 6.20B | -1.20% | 335,358 | 1.90M |
| 51 | XENE | Xenon Pharmaceuticals Inc. | 6.18B | 5.58% | 1,295,950 | 7.50M |
| 52 | PTCT | PTC Therapeutics, Inc. | 6.07B | -1.06% | 533,615 | 1.01B |
| 53 | DFTX | Definium Therapeutics, Inc. | 5.88B | -2.32% | 1,599,043 | - |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 5.74B | 2.18% | 147,461 | 290.54M |
| 55 | CRSP | CRISPR Therapeutics AG | 5.73B | -2.74% | 954,105 | 13.39M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 5.10B | -3.24% | 1,336,140 | 1.14B |
| 57 | DYN | Dyne Therapeutics, Inc. | 4.92B | 0.08% | 1,402,821 | - |
| 58 | PBLS | Parabilis Medicines, Inc. | 4.85B | 0.08% | 409,049 | 148.00K |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.82B | 0.38% | 814,071 | - |
| 60 | CELC | Celcuity Inc. | 4.65B | 3.05% | 655,356 | - |
| 61 | ELVN | Enliven Therapeutics, Inc. | 4.46B | -0.24% | 971,127 | - |
| 62 | MANE | Veradermics, Incorporated | 4.29B | 0.44% | 657,047 | - |
| 63 | TNGX | Tango Therapeutics, Inc. | 4.29B | 2.83% | 3,174,406 | 53.81M |
| 64 | RLAY | Relay Therapeutics, Inc. | 4.26B | -5.40% | 2,936,555 | 10.35M |
| 65 | IDYA | IDEAYA Biosciences, Inc. | 4.01B | -2.12% | 724,889 | 234.13M |
| 66 | VKTX | Viking Therapeutics, Inc. | 4.01B | 0.61% | 1,143,868 | - |
| 67 | LEGN | Legend Biotech Corporation | 4.01B | -2.91% | 922,786 | 1.27B |
| 68 | ABCL | AbCellera Biologics Inc. | 3.97B | -2.08% | 4,813,295 | 66.17M |
| 69 | DNLI | Denali Therapeutics Inc. | 3.93B | -1.44% | 771,232 | 3.60M |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.92B | -2.57% | 560,586 | 117.00M |
| 71 | TLX | Telix Pharmaceuticals Limited | 3.77B | -4.79% | 123,256 | 890.79M |
| 72 | IOVA | Iovance Biotherapeutics, Inc. | 3.66B | -4.27% | 9,996,493 | 324.97M |
| 73 | QURE | uniQure N.V. | 3.53B | -0.20% | 823,188 | 18.67M |
| 74 | GPCR | Structure Therapeutics Inc. | 3.52B | -1.14% | 937,153 | - |
| 75 | NAMS | NewAmsterdam Pharma Company N.V. | 3.28B | 0.22% | 758,705 | 7.12M |
| 76 | IMNM | Immunome, Inc. | 3.27B | -2.16% | 558,767 | 4.02M |
| 77 | MBX | MBX Biosciences, Inc. | 3.22B | -2.71% | 214,624 | - |
| 78 | CLDX | Celldex Therapeutics, Inc. | 3.19B | -1.58% | 540,650 | 158.00K |
| 79 | IRON | Disc Medicine, Inc. | 3.17B | 0.32% | 556,890 | - |
| 80 | ARQT | Arcutis Biotherapeutics, Inc. | 3.16B | 1.13% | 1,911,323 | 463.98M |
| 81 | TARS | Tarsus Pharmaceuticals, Inc. | 3.10B | -1.12% | 611,549 | 606.33M |
| 82 | ALMS | Alumis Inc. | 3.06B | -1.42% | 642,509 | 7.40M |
| 83 | BEAM | Beam Therapeutics Inc. | 3.02B | -2.71% | 1,389,030 | 156.04M |
| 84 | ZLAB | Zai Lab Limited | 2.92B | -0.53% | 1,140,885 | 449.61M |
| 85 | SLS | SELLAS Life Sciences Group, Inc. | 2.77B | -2.56% | 4,580,636 | - |
| 86 | NRIX | Nurix Therapeutics, Inc. | 2.77B | -0.89% | 551,874 | 36.77M |
| 87 | VRDN | Viridian Therapeutics, Inc. | 2.75B | 0.33% | 780,742 | 71.13M |
| 88 | ATAI | AtaiBeckley Inc. | 2.74B | -0.67% | 3,525,211 | 4.47M |
| 89 | PGEN | Precigen, Inc. | 2.66B | 1.92% | 6,799,795 | 85.72M |
| 90 | VERA | Vera Therapeutics, Inc. | 2.65B | 4.37% | 2,378,134 | - |
| 91 | RARE | Ultragenyx Pharmaceutical Inc. | 2.60B | -0.08% | 1,666,376 | 717.00M |
| 92 | PHVS | Pharvaris N.V. | 2.60B | -0.62% | 448,879 | - |
| 93 | BHVN | Biohaven Ltd. | 2.56B | 17.87% | 15,762,337 | - |
| 94 | TRVI | Trevi Therapeutics, Inc. | 2.55B | -0.17% | 1,207,760 | - |
| 95 | RAPP | Rapport Therapeutics, Inc. | 2.52B | 2.60% | 275,088 | 20.00M |
| 96 | NKTR | Nektar Therapeutics | 2.52B | -1.59% | 450,245 | 54.59M |
| 97 | KOD | Kodiak Sciences Inc. | 2.47B | -0.33% | 296,779 | - |
| 98 | NUVB | Nuvation Bio Inc. | 2.44B | -1.97% | 3,440,020 | 169.90M |
| 99 | KLRA | Kailera Therapeutics, Inc. | 2.39B | 3.89% | 785,292 | - |
| 100 | OCUL | Ocular Therapeutix, Inc. | 2.37B | -1.01% | 1,130,971 | 52.06M |
| 101 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.31B | -1.11% | 5,538,702 | 208.78M |
| 102 | HRMY | Harmony Biosciences Holdings, Inc. | 2.31B | 1.82% | 744,709 | 959.90M |
| 103 | COAG | Hemab Therapeutics Holdings, Inc. | 2.30B | -0.93% | 334,192 | - |
| 104 | MLYS | Mineralys Therapeutics, Inc. | 2.29B | -1.71% | 766,384 | - |
| 105 | URGN | UroGen Pharma Ltd. | 2.25B | -0.91% | 620,205 | 188.73M |
| 106 | PVLA | Palvella Therapeutics, Inc. | 2.22B | 4.11% | 194,222 | - |
| 107 | AUPH | Aurinia Pharmaceuticals Inc. | 2.20B | -1.25% | 777,918 | 311.51M |
| 108 | MESO | Mesoblast Limited | 2.20B | -2.04% | 108,391 | 65.38M |
| 109 | VCEL | Vericel Corporation | 2.17B | -1.80% | 313,605 | 306.30M |
| 110 | ADMA | ADMA Biologics, Inc. | 2.16B | -0.93% | 1,370,790 | 512.28M |
| 111 | ZBIO | Zenas BioPharma, Inc. | 2.15B | -2.16% | 651,481 | 1.00M |
| 112 | STOK | Stoke Therapeutics, Inc. | 2.14B | -1.11% | 1,155,275 | 27.59M |
| 113 | XNCR | Xencor, Inc. | 2.11B | -2.94% | 2,121,282 | 104.97M |
| 114 | ZYME | Zymeworks Inc. | 2.08B | 6.68% | 1,214,908 | 37.13M |
| 115 | GENB | Generate Biomedicines, Inc. | 2.07B | -20.80% | 3,736,428 | 26.48M |
| 116 | SRPT | Sarepta Therapeutics, Inc. | 2.06B | 2.85% | 2,409,796 | 1.97B |
| 117 | NBTX | Nanobiotix S.A. | 2.05B | 7.20% | 240,405 | 38.27M |
| 118 | AGIO | Agios Pharmaceuticals, Inc. | 2.03B | 0.27% | 812,040 | 98.34M |
| 119 | GHRS | GH Research PLC | 1.99B | 0.31% | 145,071 | - |
| 120 | KARD | Kardigan, Inc. | 1.98B | 1.24% | 214,305 | - |
| 121 | TSHA | Taysha Gene Therapies, Inc. | 1.96B | -2.90% | 1,280,745 | 5.49M |
| 122 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.03% | 1,392,430 | - |
| 123 | LKFT | Lakefront Biotherapeutics NV | 1.91B | -1.82% | 172,513 | 1.13B |
| 124 | IMCR | Immunocore Holdings plc | 1.91B | -0.75% | 255,279 | 430.78M |
| 125 | SEPN | Septerna, Inc. | 1.88B | -2.54% | 168,176 | 98.88M |
| 126 | DMRA | Damora Therapeutics, Inc. | 1.88B | -0.75% | 185,906 | - |
| 127 | VIR | Vir Biotechnology, Inc. | 1.87B | 3.45% | 2,248,493 | 303.23M |
| 128 | RXRX | Recursion Pharmaceuticals, Inc. | 1.87B | -1.97% | 12,897,730 | 54.86M |
| 129 | NTLA | Intellia Therapeutics, Inc. | 1.85B | -2.37% | 2,696,889 | 59.51M |
| 130 | INBX | Inhibrx Biosciences, Inc. | 1.84B | 2.13% | 302,757 | 1.30M |
| 131 | SNDX | Syndax Pharmaceuticals, Inc. | 1.79B | 0.85% | 789,962 | 252.25M |
| 132 | BRVE | Braveheart Bio, Inc. | 1.78B | 0.43% | 215,203 | - |
| 133 | FTRE | Fortrea Holdings Inc. | 1.76B | 1.42% | 598,294 | 2.68B |
| 134 | ANAB | AnaptysBio, Inc. | 1.72B | -0.63% | 210,234 | 232.39M |
| 135 | MAZE | Maze Therapeutics, Inc. | 1.64B | -2.76% | 229,997 | 20.00M |
| 136 | AVLN | Avalyn Pharma Inc. | 1.64B | -3.04% | 142,600 | - |
| 137 | APMD | Apnimed, Inc. | 1.64B | 8.07% | 333,988 | 120.15M |
| 138 | BCAX | Bicara Therapeutics Inc. | 1.64B | 0.61% | 423,819 | - |
| 139 | ABSI | Absci Corporation | 1.58B | -4.26% | 2,675,922 | 1.56M |
| 140 | TRAX | First Tracks Biotherapeutics, Inc. | 1.58B | -2.04% | 561,658 | - |
| 141 | TYRA | Tyra Biosciences, Inc. | 1.56B | -1.76% | 286,831 | - |
| 142 | LBRX | LB Pharmaceuticals Inc | 1.55B | -1.30% | 244,899 | - |
| 143 | AAPG | Ascentage Pharma Group International | 1.55B | 0.66% | 4,845 | 94.61M |
| 144 | AVBP | ArriVent BioPharma, Inc. | 1.54B | -0.67% | 433,837 | - |
| 145 | INVA | Innoviva, Inc. | 1.53B | 0.33% | 693,028 | 440.00M |
| 146 | LTGO | Latigo Biotherapeutics, Inc. | 1.53B | 6.91% | 137,934 | - |
| 147 | NVAX | Novavax, Inc. | 1.52B | -2.44% | 3,507,665 | 413.80M |
| 148 | REPL | Replimune Group, Inc. | 1.50B | 0.51% | 2,374,854 | - |
| 149 | SPTX | Seaport Therapeutics, Inc. | 1.49B | 12.36% | 135,680 | - |
| 150 | SLBT | SL Science Holding Limited | 1.48B | -1.52% | 20,253 | 3.27M |
| 151 | AKTS | Aktis Oncology, Inc. | 1.47B | -0.67% | 257,124 | 10.06M |
| 152 | CGEM | Cullinan Therapeutics, Inc. | 1.47B | -0.44% | 683,292 | - |
| 153 | ORIC | ORIC Pharmaceuticals, Inc. | 1.44B | 0.58% | 1,123,726 | - |
| 154 | ANRO | Alto Neuroscience, Inc. | 1.43B | 0.61% | 282,847 | - |
| 155 | SVRA | Savara Inc. | 1.43B | 0.18% | 1,529,744 | - |
| 156 | VOR | Vor Biopharma Inc. | 1.40B | -1.42% | 448,004 | - |
| 157 | MGTX | MeiraGTx Holdings plc | 1.40B | -2.41% | 606,281 | 397.50M |
| 158 | DRTS | Alpha Tau Medical Ltd. | 1.38B | 1.77% | 432,893 | - |
| 159 | JBIO | Jade Biosciences, Inc. | 1.36B | -2.34% | 355,912 | - |
| 160 | MLTX | MoonLake Immunotherapeutics | 1.33B | 0.39% | 999,922 | - |
| 161 | OMER | Omeros Corporation | 1.32B | -5.50% | 1,407,853 | 38.42M |
| 162 | MNKD | MannKind Corporation | 1.32B | -1.68% | 1,766,297 | 393.63M |
| 163 | IMTX | Immatics N.V. | 1.29B | 2.06% | 777,952 | 47.65M |
| 164 | SANA | Sana Biotechnology, Inc. | 1.25B | 1.46% | 2,293,554 | - |
| 165 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | 1.17% | 692,813 | - |
| 166 | ODTX | Odyssey Therapeutics, Inc. | 1.23B | -2.33% | 235,722 | 99.00K |
| 167 | GLUE | Monte Rosa Therapeutics, Inc. | 1.23B | -1.24% | 997,709 | 28.73M |
| 168 | KURA | Kura Oncology, Inc. | 1.16B | -3.90% | 2,255,137 | 77.23M |
| 169 | JANX | Janux Therapeutics, Inc. | 1.15B | 1.12% | 523,779 | 24.00M |
| 170 | IVA | Inventiva S.A. | 1.14B | 2.77% | 924,331 | 7.94M |
| 171 | AVTX | Avalo Therapeutics, Inc. | 1.10B | 4.10% | 813,930 | 59.00K |
| 172 | SLDB | Solid Biosciences Inc. | 1.04B | -1.72% | 594,133 | - |
| 173 | WVE | Wave Life Sciences, Inc. | 1.03B | -0.38% | 2,197,209 | 65.37M |
| 174 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | -1.28% | 1,087,043 | 41.47M |
| 175 | ABUS | Arbutus Biopharma Corporation | 1.03B | -0.19% | 4,596,532 | 181.72M |
| 176 | CADL | Candel Therapeutics, Inc. | 1.02B | -2.35% | 977,968 | - |
| 177 | IMMX | Immix Biopharma, Inc. | 1.01B | -2.76% | 1,385,243 | - |
| 178 | HELP | Cybin Inc. | 995.81M | -2.54% | 1,557,517 | - |
| 179 | GERN | Geron Corporation | 982.98M | -1.29% | 9,118,155 | 204.56M |
| 180 | DSGN | Design Therapeutics, Inc. | 975.65M | -0.57% | 718,671 | - |
| 181 | ANL | Adlai Nortye Ltd. | 969.83M | 9.61% | 144,864 | 18.06M |
| 182 | ARDX | Ardelyx, Inc. | 954.39M | 1.32% | 2,914,847 | 450.89M |
| 183 | OLMA | Olema Pharmaceuticals, Inc. | 949.35M | -0.55% | 471,899 | - |
| 184 | ANNX | Annexon, Inc. | 946.00M | -3.11% | 2,275,143 | - |
| 185 | CLYM | Climb Bio, Inc. | 923.57M | -9.87% | 1,392,210 | - |
| 186 | ACRS | Aclaris Therapeutics, Inc. | 911.16M | -5.28% | 1,735,936 | 8.22M |
| 187 | SGP | SpyGlass Pharma, Inc. | 891.05M | 0.15% | 74,461 | - |
| 188 | TBPH | Theravance Biopharma, Inc. | 884.18M | - | 190,120 | 104.31M |
| 189 | RIGL | Rigel Pharmaceuticals, Inc. | 868.24M | -0.58% | 232,249 | 276.79M |
| 190 | FDMT | 4D Molecular Therapeutics, Inc. | 859.60M | -1.02% | 717,881 | 92.01M |
| 191 | FTH | Faeth Therapeutics, Inc. | 851.96M | -4.49% | 140,894 | - |
| 192 | ACHV | Achieve Life Sciences, Inc. | 851.00M | 1.22% | 1,322,219 | - |
| 193 | DBVT | DBV Technologies S.A. | 848.13M | -3.01% | 242,524 | 5.04M |
| 194 | ATTO | Attovia Therapeutics, Inc. | 834.76M | 0.47% | 143,297 | 1.35M |
| 195 | PHAR | Pharming Group N.V. | 829.58M | 1.53% | 35,539 | 366.48M |
| 196 | SLN | Silence Therapeutics plc | 814.63M | -1.02% | 301,696 | 615.00K |
| 197 | NVCT | Nuvectis Pharma, Inc. | 814.54M | -3.44% | 362,380 | - |
| 198 | AURA | Aura Biosciences, Inc. | 801.64M | -1.15% | 557,594 | - |
| 199 | OCS | Oculis Holding AG | 800.66M | 0.08% | 161,146 | 1.45M |
| 200 | OBX | Obsidian Therapeutics, Inc. | 797.20M | -3.16% | 118,358 | - |
| 201 | STTK | Shattuck Labs, Inc. | 792.87M | -1.99% | 581,614 | 1.00M |
| 202 | CBIO | Crescent Biopharma, Inc. | 771.28M | 6.00% | 317,533 | 11.88M |
| 203 | NGNE | Neurogene Inc. | 768.64M | -5.95% | 180,118 | 925.00K |
| 204 | MNPR | Monopar Therapeutics Inc. | 763.31M | 2.62% | 123,663 | - |
| 205 | DRUG | Bright Minds Biosciences Inc. | 760.37M | -3.60% | 70,553 | - |
| 206 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 742.41M | -1.17% | 247,132 | - |
| 207 | CTMX | CytomX Therapeutics, Inc. | 723.43M | -1.48% | 2,216,277 | 18.30M |
| 208 | ASMB | Assembly Biosciences, Inc. | 721.17M | 0.25% | 171,431 | 74.85M |
| 209 | MPLT | MapLight Therapeutics, Inc. | 714.70M | 2.55% | 909,953 | - |
| 210 | GYRE | Gyre Therapeutics, Inc. | 705.12M | -0.45% | 38,753 | 109.82M |
| 211 | ALLO | Allogene Therapeutics, Inc. | 704.80M | -5.99% | 5,020,078 | 4.64M |
| 212 | AGMB | AgomAb Therapeutics NV | 703.26M | 1.85% | 243,636 | - |
| 213 | TECX | Tectonic Therapeutic, Inc. | 703.19M | -4.61% | 145,120 | - |
| 214 | OABI | OmniAb, Inc. | 699.33M | 3.22% | 1,439,824 | 38.46M |
| 215 | ZVRA | Zevra Therapeutics, Inc. | 697.17M | -2.49% | 555,407 | 136.07M |
| 216 | PHAT | Phathom Pharmaceuticals, Inc. | 696.60M | -0.34% | 800,559 | 239.66M |
| 217 | PRLD | Prelude Therapeutics Incorporated | 675.65M | -0.46% | 462,796 | 22.42M |
| 218 | SGMT | Sagimet Biosciences Inc. | 675.04M | 5.54% | 1,236,901 | - |
| 219 | VSTM | Verastem, Inc. | 669.26M | 4.38% | 1,681,932 | 87.53M |
| 220 | CRMD | CorMedix Inc. | 653.95M | -1.99% | 865,407 | 462.25M |
| 221 | EIKN | Eikon Therapeutics, Inc. | 648.90M | -4.54% | 322,769 | - |
| 222 | MDXG | MiMedx Group, Inc. | 644.26M | 1.84% | 710,950 | 355.17M |
| 223 | CTNM | Contineum Therapeutics, Inc. | 640.31M | -0.18% | 387,857 | - |
| 224 | PRME | Prime Medicine, Inc. | 636.90M | -3.50% | 1,950,187 | 4.07M |
| 225 | VALN | Valneva SE | 627.52M | -1.25% | 28,237 | 163.30M |
| 226 | AUTL | Autolus Therapeutics plc | 620.16M | -4.51% | 1,307,924 | 117.39M |
| 227 | RGNX | REGENXBIO Inc. | 619.20M | 5.27% | 1,157,979 | 174.48M |
| 228 | ALT | Altimmune, Inc. | 612.73M | -1.56% | 4,046,966 | 31.00K |
| 229 | ARVN | Arvinas, Inc. | 609.40M | -2.92% | 532,421 | 316.70M |
| 230 | SPRY | ARS Pharmaceuticals, Inc. | 599.67M | 5.42% | 956,130 | 116.93M |
| 231 | SCTX | Scribe Therapeutics Inc. | 598.00M | 1.59% | 245,107 | 36.28M |
| 232 | ARTV | Artiva Biotherapeutics, Inc. | 575.44M | - | 262,317 | 251.00K |
| 233 | ZURA | Zura Bio Limited | 574.02M | -5.22% | 1,670,261 | - |
| 234 | BLSM | BlossomHill Therapeutics, Inc. | 565.68M | 0.22% | 55,698 | - |
| 235 | OVID | Ovid Therapeutics Inc. | 562.46M | -1.03% | 1,143,140 | 1.58M |
| 236 | ENTX | Entera Bio Ltd. | 552.32M | -8.07% | 511,746 | 42.00K |
| 237 | CABA | Cabaletta Bio, Inc. | 551.02M | 0.93% | 2,484,413 | - |
| 238 | CAPR | Capricor Therapeutics, Inc. | 544.18M | 12.91% | 11,627,458 | 11.13M |
| 239 | KYTX | Kyverna Therapeutics, Inc. | 532.47M | -2.60% | 413,774 | - |
| 240 | RZLT | Rezolute, Inc. | 526.51M | 0.60% | 1,367,982 | - |
| 241 | PROK | ProKidney Corp. | 526.04M | 0.58% | 564,569 | 818.00K |
| 242 | CCCC | C4 Therapeutics, Inc. | 521.63M | 0.95% | 1,862,135 | 35.04M |
| 243 | EVMN | Evommune, Inc. | 512.08M | 2.32% | 342,129 | 10.00M |
| 244 | EDIT | Editas Medicine, Inc. | 488.38M | -3.05% | 2,944,119 | 47.01M |
| 245 | DNA | Ginkgo Bioworks Holdings, Inc. | 486.87M | -4.11% | 628,754 | 132.42M |
| 246 | EPRX | Eupraxia Pharmaceuticals Inc. | 485.68M | 0.13% | 235,390 | - |
| 247 | RLMD | Relmada Therapeutics, Inc. | 485.35M | -0.87% | 476,693 | - |
| 248 | QTTB | Q32 Bio Inc. | 481.67M | -0.86% | 327,029 | 53.74M |
| 249 | OCGN | Ocugen, Inc. | 478.15M | 0.71% | 1,740,021 | 4.58M |
| 250 | PRTA | Prothena Corporation plc | 474.87M | -1.80% | 289,036 | 54.53M |
| 251 | PBYI | Puma Biotechnology, Inc. | 472.84M | -1.72% | 374,455 | 231.24M |
| 252 | VOGX | Vogenx, Inc. | 457.61M | 4.28% | 266,424 | - |
| 253 | IKT | Inhibikase Therapeutics, Inc. | 453.37M | -0.40% | 244,018 | 1.00 |
| 254 | ARCT | Arcturus Therapeutics Holdings Inc. | 449.94M | 2.53% | 2,225,455 | 29.37M |
| 255 | BNTC | Benitec Biopharma Inc. | 442.48M | -1.08% | 64,628 | - |
| 256 | AVIR | Atea Pharmaceuticals, Inc. | 441.93M | 1.47% | 214,076 | - |
| 257 | CMPX | Compass Therapeutics, Inc. | 437.61M | -3.95% | 1,444,736 | 850.00K |
| 258 | LRMR | Larimar Therapeutics, Inc. | 435.28M | 0.24% | 702,123 | - |
| 259 | EYPT | EyePoint, Inc. | 430.20M | -0.30% | 2,808,859 | 2.79M |
| 260 | FENC | Fennec Pharmaceuticals Inc. | 426.77M | 3.93% | 250,951 | 59.22M |
| 261 | GALT | Galectin Therapeutics Inc. | 418.53M | 4.01% | 291,095 | - |
| 262 | VTVT | vTv Therapeutics Inc. | 417.10M | -1.00% | 117,243 | 36.84M |
| 263 | XFOR | X4 Pharmaceuticals, Inc. | 413.44M | 0.24% | 707,141 | 15.85M |
| 264 | ENTA | Enanta Pharmaceuticals, Inc. | 412.12M | 0.50% | 156,202 | 65.26M |
| 265 | LXEO | Lexeo Therapeutics, Inc. | 411.03M | -2.34% | 689,958 | - |
| 266 | RCKT | Rocket Pharmaceuticals, Inc. | 401.78M | -3.17% | 1,120,219 | - |
| 267 | FHTX | Foghorn Therapeutics Inc. | 397.29M | -2.34% | 318,746 | 36.74M |
| 268 | UPB | Upstream Bio, Inc. | 390.52M | -0.70% | 432,930 | 3.16M |
| 269 | IPSC | Century Therapeutics, Inc. | 387.50M | -1.38% | 313,485 | 109.16M |
| 270 | CUVL | Clinuvel Pharmaceuticals Limited | 380.21M | 0.58% | 1,336 | 64.24M |
| 271 | AGEN | Agenus Inc. | 371.42M | -1.32% | 716,581 | 132.69M |
| 272 | PALI | Palisade Bio, Inc. | 371.20M | 2.90% | 1,190,448 | 500.00K |
| 273 | ZNTL | Zentalis Pharmaceuticals, Inc. | 368.27M | 0.26% | 576,123 | 26.87M |
| 274 | LYEL | Lyell Immunopharma, Inc. | 362.68M | -4.45% | 87,751 | 27.00K |
| 275 | DMAC | DiaMedica Therapeutics Inc. | 361.30M | -0.59% | 118,269 | - |
| 276 | IFRX | InflaRx N.V. | 356.63M | -1.63% | 1,714,116 | -11.54K |
| 277 | STRO | Sutro Biopharma, Inc. | 355.33M | -0.05% | 214,929 | 45.70M |
| 278 | SABS | SAB Biotherapeutics, Inc. | 353.03M | 1.84% | 274,416 | 114.70K |
| 279 | ABEO | Abeona Therapeutics Inc. | 343.68M | -3.22% | 1,187,675 | 25.52M |
| 280 | IMRX | Immuneering Corporation | 333.19M | -1.53% | 460,668 | - |
| 281 | PRQR | ProQR Therapeutics N.V. | 331.64M | -1.26% | 649,698 | 21.05M |
| 282 | VNDA | Vanda Pharmaceuticals Inc. | 323.48M | -1.65% | 928,369 | 215.72M |
| 283 | OBIO | Orchestra BioMed Holdings, Inc. | 316.15M | -1.87% | 391,688 | 31.98M |
| 284 | IRD | Opus Genetics, Inc. | 316.14M | -7.54% | 837,463 | 9.86M |
| 285 | VCRE | Vicore Pharma Holding AB (publ) | 314.78M | -1.48% | 3,539 | 412.09K |
| 286 | RNAC | Cartesian Therapeutics, Inc. | 308.30M | -1.83% | 65,802 | 1.48M |
| 287 | FATE | Fate Therapeutics, Inc. | 307.94M | 0.78% | 1,049,000 | 6.49M |
| 288 | YDES | YD Bio Limited | 305.19M | -7.26% | 11,367 | 510.36K |
| 289 | BCYC | Bicycle Therapeutics plc | 304.82M | -0.80% | 166,144 | 61.21M |
| 290 | AVXL | Anavex Life Sciences Corp. | 300.26M | -8.99% | 1,180,201 | - |
| 291 | FULC | Fulcrum Therapeutics, Inc. | 294.51M | - | 854,829 | 80.00M |
| 292 | NMRA | Neumora Therapeutics, Inc. | 293.12M | 4.00% | 535,854 | - |
| 293 | TTRX | Turn Therapeutics Inc. | 286.86M | -1.03% | 69,207 | - |
| 294 | ACIU | AC Immune SA | 283.37M | -2.40% | 269,055 | 21.67M |
| 295 | LCTX | Lineage Cell Therapeutics, Inc. | 283.26M | -0.88% | 768,149 | 13.08M |
| 296 | SION | Sionna Therapeutics, Inc. | 278.96M | -1.28% | 803,971 | - |
| 297 | SRZN | Surrozen, Inc. | 278.68M | 1.50% | 128,739 | 11.51M |
| 298 | PYXS | Pyxis Oncology, Inc. | 278.58M | 9.15% | 604,058 | 11.04M |
| 299 | WHWK | Whitehawk Therapeutics, Inc. | 275.92M | -4.72% | 135,971 | 7.15M |
| 300 | ALEC | Alector, Inc. | 274.68M | 4.24% | 995,457 | 13.86M |
| 301 | ALXO | ALX Oncology Holdings Inc. | 273.79M | -1.00% | 385,052 | - |
| 302 | ELDN | Eledon Pharmaceuticals, Inc. | 272.49M | -3.46% | 816,300 | - |
| 303 | CGEN | Compugen Ltd. | 269.02M | -1.05% | 667,033 | 74.00M |
| 304 | GLSI | Greenwich LifeSciences, Inc. | 267.58M | -1.94% | 54,132 | - |
| 305 | IVVD | Invivyd, Inc. | 265.78M | -3.94% | 3,626,846 | 58.37M |
| 306 | CAMP | Camp4 Therapeutics Corporation | 263.56M | -5.62% | 364,502 | 4.22M |
| 307 | NAGE | Niagen Bioscience, Inc. | 261.67M | 0.92% | 385,108 | 129.08M |
| 308 | SLGL | Sol-Gel Technologies Ltd. | 260.05M | -2.80% | 68,604 | 1.80M |
| 309 | NERV | Minerva Neurosciences, Inc. | 259.27M | 8.60% | 383,956 | - |
| 310 | ADAG | Adagene Inc. | 258.50M | 0.79% | 122,040 | 9.29M |
| 311 | MGNX | MacroGenics, Inc. | 257.35M | -3.12% | 262,928 | 175.14M |
| 312 | CLLS | Cellectis S.A. | 256.64M | - | 17,865 | 63.82M |
| 313 | TRDA | Entrada Therapeutics, Inc. | 252.40M | -8.14% | 229,319 | 4.69M |
| 314 | NGEN | NervGen Pharma Corp. | 237.63M | 6.25% | 468,969 | - |
| 315 | RNA | Atrium Therapeutics, Inc. | 236.91M | -1.07% | 179,337 | 35.84M |
| 316 | DTIL | Precision BioSciences, Inc. | 234.34M | -0.70% | 262,643 | 45.06M |
| 317 | TNXP | Tonix Pharmaceuticals Holding Corp. | 233.94M | -0.15% | 513,959 | 29.10M |
| 318 | TARA | Protara Therapeutics, Inc. | 231.06M | -1.51% | 709,727 | - |
| 319 | IMUX | Immunic, Inc. | 225.00M | 0.43% | 240,737 | - |
| 320 | CHRS | Coherus Oncology, Inc. | 224.03M | 5.84% | 896,489 | 50.94M |
| 321 | PEPG | PepGen Inc. | 223.02M | -5.99% | 951,747 | - |
| 322 | ORMP | Oramed Pharmaceuticals Inc. | 222.13M | 2.50% | 401,667 | 2.00M |
| 323 | KROS | Keros Therapeutics, Inc. | 220.48M | -4.79% | 113,585 | 15.01M |
| 324 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 218.56M | -0.09% | 391,787 | - |
| 325 | NBP | NovaBridge Biosciences | 216.92M | -3.11% | 218,443 | - |
| 326 | ABOS | Acumen Pharmaceuticals, Inc. | 216.23M | -3.55% | 234,999 | - |
| 327 | VYGR | Voyager Therapeutics, Inc. | 213.20M | -0.57% | 246,903 | 34.46M |
| 328 | CUE | Cue Biopharma, Inc. | 209.58M | 7.81% | 205,054 | 37.66M |
| 329 | ANTX | AN2 Therapeutics, Inc. | 208.68M | -2.30% | 287,073 | - |
| 330 | ACOG | Alpha Cognition Inc. | 204.93M | -3.49% | 251,837 | 15.26M |
| 331 | ARMP | Armata Pharmaceuticals, Inc. | 202.64M | -1.98% | 54,743 | 5.54M |
| 332 | IPHA | Innate Pharma S.A. | 201.78M | -4.85% | 20,468 | 10.57M |
| 333 | KRRO | Korro Bio, Inc. | 201.45M | -0.36% | 40,981 | 2.38M |
| 334 | PLX | Protalix BioTherapeutics, Inc. | 199.82M | 3.33% | 1,001,879 | 80.62M |
| 335 | MSLE | Satellos Bioscience Inc. | 199.27M | -0.43% | 10,234 | - |
| 336 | HUMA | Humacyte, Inc. | 189.35M | -2.80% | 5,676,964 | 2.12M |
| 337 | NKTX | Nkarta, Inc. | 188.37M | -2.95% | 260,757 | - |
| 338 | CNXU | Conexeu Sciences Inc. | 186.64M | -7.62% | 291,508 | - |
| 339 | CDXS | Codexis, Inc. | 180.68M | -1.79% | 559,868 | 77.68M |
| 340 | CNTN | Canton Strategic Holdings, Inc. | 177.69M | -3.46% | 508,173 | 1.50M |
| 341 | CRBU | Caribou Biosciences, Inc. | 176.89M | -6.25% | 840,939 | 10.04M |
| 342 | SPRB | Spruce Biosciences, Inc. | 176.69M | -3.03% | 91,536 | 697.00K |
| 343 | KZIA | Kazia Therapeutics Limited | 166.83M | 5.87% | 98,557 | 1.27M |
| 344 | MENS | Jyong Biotech Ltd. | 166.28M | 0.45% | 23,626 | - |
| 345 | MIST | Milestone Pharmaceuticals Inc. | 166.27M | 1.72% | 726,869 | 2.34M |
| 346 | MDWD | MediWound Ltd. | 163.96M | -2.08% | 209,553 | 11.86M |
| 347 | MOLN | Molecular Partners AG | 162.68M | 1.60% | 2,389 | 856.30K |
| 348 | TNYA | Tenaya Therapeutics, Inc. | 156.11M | -0.74% | 903,239 | 1.34M |
| 349 | OKUR | OnKure Therapeutics, Inc. | 153.89M | -1.30% | 66,962 | - |
| 350 | INDP | Indaptus Therapeutics, Inc. | 151.90M | 4.11% | 205,224 | - |
| 351 | OTLK | Outlook Therapeutics, Inc. | 151.74M | -2.61% | 5,948,135 | -1.16M |
| 352 | UNCY | Unicycive Therapeutics, Inc. | 151.25M | -0.73% | 906,194 | - |
| 353 | LENZ | LENZ Therapeutics, Inc. | 150.19M | 2.36% | 544,997 | 21.48M |
| 354 | NRXP | NRx Pharmaceuticals, Inc. | 149.69M | -5.72% | 1,003,986 | 3.39M |
| 355 | EQ | Equillium, Inc. | 149.64M | 8.26% | 698,683 | 4.39M |
| 356 | AARD | Aardvark Therapeutics, Inc. | 149.04M | -6.07% | 111,925 | - |
| 357 | CNTB | Connect Biopharma Holdings Limited | 146.73M | -4.90% | 371,733 | 2.95M |
| 358 | TLSA | Tiziana Life Sciences Ltd | 140.95M | -1.80% | 402,567 | - |
| 359 | HURA | TuHURA Biosciences, Inc. | 135.74M | 4.41% | 158,742 | - |
| 360 | INO | Inovio Pharmaceuticals, Inc. | 134.42M | 0.78% | 3,670,926 | 65.34K |
| 361 | ENGN | enGene Therapeutics Inc. | 130.63M | 4.28% | 1,827,489 | - |
| 362 | BDTX | Black Diamond Therapeutics, Inc. | 130.42M | 1.34% | 491,238 | 70.00M |
| 363 | PMN | ProMIS Neurosciences, Inc. | 129.67M | -5.86% | 32,190 | - |
| 364 | CBUS | Cibus, Inc. | 128.40M | - | 89,860 | 4.35M |
| 365 | VANI | Vivani Medical, Inc. | 127.64M | -0.35% | 215,535 | - |
| 366 | BMEA | Biomea Fusion, Inc. | 123.95M | -1.16% | 3,215,925 | - |
| 367 | ANIX | Anixa Biosciences, Inc. | 122.65M | -1.50% | 291,263 | - |
| 368 | GNLX | Genelux Corporation | 122.34M | 0.37% | 300,081 | 8.00K |
| 369 | TENX | Tenax Therapeutics, Inc. | 121.44M | -8.62% | 4,892,430 | - |
| 370 | NAUT | Nautilus Biotechnology, Inc. | 119.29M | 6.37% | 845,097 | 190.00K |
| 371 | GUTS | Fractyl Health, Inc. | 117.33M | -5.96% | 1,151,958 | 3.00K |
| 372 | RANI | Rani Therapeutics Holdings, Inc. | 117.29M | -5.57% | 512,052 | 4.88M |
| 373 | COYA | Coya Therapeutics, Inc. | 114.24M | -3.37% | 54,387 | 8.02M |
| 374 | NTHI | NeOnc Technologies Holdings, Inc. | 113.35M | -3.18% | 119,910 | 39.99K |
| 375 | SEER | Seer, Inc. | 111.85M | -0.98% | 124,499 | 14.22M |
| 376 | YARW | Yarrow Bioscience, Inc. | 110.98M | 0.98% | 31,203 | - |
| 377 | ONCY | Oncolytics Biotech Inc. | 109.10M | -0.67% | 410,055 | - |
| 378 | PLYX | Polaryx Therapeutics, Inc. | 104.18M | 5.03% | 113,409 | - |
| 379 | PYPD | PolyPid Ltd. | 103.79M | 0.20% | 149,339 | - |
| 380 | PTHS | Pelthos Therapeutics Inc. | 102.53M | -1.54% | 35,033 | 43.30M |
| 381 | CGTX | Cognition Therapeutics, Inc. | 99.85M | 1.94% | 466,156 | - |
| 382 | KLRS | Kalaris Therapeutics, Inc. | 97.12M | -2.86% | 28,245 | - |
| 383 | ACET | Adicet Bio, Inc. | 96.34M | -0.56% | 119,323 | - |
| 384 | ATRA | Atara Biotherapeutics, Inc. | 94.15M | -4.67% | 63,701 | 6.19M |
| 385 | ALDX | Aldeyra Therapeutics, Inc. | 94.11M | 0.65% | 478,445 | - |
| 386 | FBIO | Fortress Biotech, Inc. | 93.72M | -0.71% | 395,817 | 68.47M |
| 387 | ICCC | ImmuCell Corporation | 91.00M | 1.83% | 7,430 | 30.68M |
| 388 | DWTX | Dogwood Therapeutics, Inc. | 90.42M | -0.75% | 120,552 | - |
| 389 | RLYB | Rallybio Corporation | 89.64M | -0.03% | 3,693 | 646.00K |
| 390 | ACRV | Acrivon Therapeutics, Inc. | 89.13M | -4.59% | 160,131 | - |
| 391 | GOSS | Gossamer Bio, Inc. | 85.01M | -14.96% | 29,071,639 | 53.29M |
| 392 | MAIA | MAIA Biotechnology, Inc. | 84.55M | -1.42% | 557,759 | - |
| 393 | VRCA | Verrica Pharmaceuticals Inc. | 84.35M | -0.61% | 27,655 | 30.32M |
| 394 | OKYO | OKYO Pharma Limited | 81.34M | -0.64% | 6,370 | - |
| 395 | TELO | Telomir Pharmaceuticals, Inc. | 80.47M | -0.85% | 69,007 | - |
| 396 | GANX | Gain Therapeutics, Inc. | 78.99M | -4.99% | 723,123 | - |
| 397 | CING | Cingulate Inc. | 78.53M | -8.01% | 157,818 | - |
| 398 | ELTX | Elicio Therapeutics, Inc. | 78.32M | -1.00% | 182,538 | - |
| 399 | ATHE | Alterity Therapeutics Limited | 77.80M | 6.94% | 63,316 | 4.43M |
| 400 | CRDF | Cardiff Oncology, Inc. | 76.56M | -3.52% | 274,451 | 508.00K |
| 401 | OSTX | OS Therapies Incorporated | 76.11M | - | 351,352 | - |
| 402 | ANVS | Annovis Bio, Inc. | 75.84M | -2.20% | 235,710 | - |
| 403 | NRXS | NeurAxis, Inc. | 74.84M | -1.32% | 60,900 | 5.32M |
| 404 | ELOX | Eloxx Pharmaceuticals, Inc. | 74.80M | -3.94% | 52,753 | - |
| 405 | LONA | LeonaBio, Inc. | 73.58M | -2.50% | 24,403 | - |
| 406 | MNOV | MediciNova, Inc. | 72.85M | -5.73% | 40,698 | 920.48K |
| 407 | PLRX | Pliant Therapeutics, Inc. | 71.83M | -2.52% | 134,963 | - |
| 408 | SPRO | Spero Therapeutics, Inc. | 71.05M | -0.81% | 154,661 | 47.00M |
| 409 | IBIO | iBio, Inc. | 71.04M | -2.72% | 259,160 | 300.00K |
| 410 | XBIT | XBiotech Inc. | 70.43M | 0.43% | 21,900 | - |
| 411 | PMVP | PMV Pharmaceuticals, Inc. | 70.03M | 0.38% | 94,453 | - |
| 412 | ALPS | Alps Group Inc | 69.87M | 33.39% | 315,192 | 3.74M |
| 413 | EXOZ | eXoZymes, Inc. | 69.84M | -0.07% | 1,461 | -700.00 |
| 414 | RNTX | Rein Therapeutics Inc. | 69.01M | - | 324,709 | - |
| 415 | CSBR | Champions Oncology, Inc. | 68.36M | -1.20% | 4,307 | 59.43M |
| 416 | INMB | INmune Bio Inc. | 67.86M | 0.62% | 419,194 | 50.00K |
| 417 | RNXT | RenovoRx, Inc. | 67.24M | 4.93% | 674,295 | 1.98M |
| 418 | HYFT | MindWalk Holdings Corp. | 67.19M | 0.70% | 84,560 | 11.43M |
| 419 | SER | Serina Therapeutics, Inc. | 66.80M | -2.59% | 14,796 | 130.00K |
| 420 | EDSA | Edesa Biotech, Inc. | 66.75M | 11.01% | 234,767 | - |
| 421 | BOLD | Boundless Bio, Inc. | 66.31M | -0.85% | 158,798 | - |
| 422 | BSEM | BioStem Technologies, Inc. | 65.33M | -3.94% | 30,382 | 34.59M |
| 423 | IMA | ImageneBio, Inc. | 61.64M | -2.16% | 9,763 | 800.00K |
| 424 | XLO | Xilio Therapeutics, Inc. | 59.55M | -0.33% | 7,619 | 64.09M |
| 425 | HRTX | Heron Therapeutics, Inc. | 59.27M | -3.37% | 2,850,033 | 151.18M |
| 426 | INKT | MiNK Therapeutics, Inc. | 58.74M | 3.60% | 8,936 | - |
| 427 | APLM | Apollomics, Inc. | 57.54M | -1.13% | 4,222 | 8.84M |
| 428 | IMMP | Immutep Limited | 54.82M | -0.50% | 35,471 | 5.28M |
| 429 | NTRB | Nutriband Inc. | 54.70M | -6.83% | 61,214 | 1.80M |
| 430 | ATYR | aTyr Pharma, Inc. | 54.05M | -3.33% | 304,793 | 190.00K |
| 431 | TIL | Instil Bio, Inc. | 53.10M | 3.03% | 10,689 | - |
| 432 | TCRX | TScan Therapeutics, Inc. | 52.69M | -2.05% | 68,346 | 7.11M |
| 433 | HYPD | Hyperion DeFi, Inc. | 52.68M | -0.59% | 339,799 | 1.40M |
| 434 | HOWL | Werewolf Therapeutics, Inc. | 48.05M | 11.10% | 11,418,394 | 21.00M |
| 435 | VERU | Veru Inc. | 47.74M | 3.32% | 169,369 | 16.89M |
| 436 | IBO | Impact BioMedical Inc. | 47.45M | -4.37% | 11,703 | 35.00K |
| 437 | MCRB | Seres Therapeutics, Inc. | 47.32M | -4.80% | 58,201 | 1.88M |
| 438 | ALGS | Aligos Therapeutics, Inc. | 46.90M | 0.54% | 68,919 | 31.52M |
| 439 | MGX | Metagenomi Therapeutics, Inc. | 46.09M | 0.83% | 59,571 | 13.56M |
| 440 | GRCE | Grace Therapeutics, Inc. | 45.23M | -2.27% | 22,208 | - |
| 441 | FLNA | Filana Therapeutics, Inc. | 44.66M | -2.57% | 56,831 | - |
| 442 | KPTI | Karyopharm Therapeutics Inc. | 44.46M | 2.08% | 753,751 | 146.62M |
| 443 | MREO | Mereo BioPharma Group plc | 44.39M | -1.28% | 943,934 | 500.00K |
| 444 | TVGN | Tevogen Inc. | 43.63M | -3.87% | 1,901 | - |
| 445 | ACTU | Actuate Therapeutics, Inc. | 42.75M | 12.66% | 3,303,686 | - |
| 446 | VRXA | Veraxa Biotech AG | 41.36M | -5.20% | 425,068 | - |
| 447 | CRVO | CervoMed Inc. | 40.07M | - | 90,231 | 331.30K |
| 448 | RNAZ | TransCode Therapeutics, Inc. | 39.62M | -7.51% | 24,023 | - |
| 449 | CNTX | Context Therapeutics Inc. | 38.93M | -2.69% | 1,011,383 | - |
| 450 | LITS | Lite Strategy, Inc. | 33.79M | -5.42% | 101,453 | - |
| 451 | KYNB | Kyntra Bio, Inc. | 32.82M | 0.06% | 7,341 | 4.62M |
| 452 | BCTX | BriaCell Therapeutics Corp. | 32.31M | 6.90% | 277,632 | - |
| 453 | QNCX | Quince Therapeutics, Inc. | 31.84M | 1.23% | 13,617 | - |
| 454 | IGC | IGC Pharma, Inc. | 31.81M | 1.02% | 441,618 | 1.11M |
| 455 | ATNM | Actinium Pharmaceuticals, Inc. | 31.76M | -6.48% | 143,327 | 35.09M |
| 456 | ESLA | Estrella Immunopharma, Inc. | 31.75M | -0.34% | 11,864 | - |
| 457 | RADX | Radiopharm Theranostics Limited | 31.09M | -6.45% | 21,667 | 10.86M |
| 458 | NNVC | NanoViricides, Inc. | 29.16M | -0.78% | 180,191 | - |
| 459 | BRNS | Barinthus Biotherapeutics plc | 28.86M | 7.03% | 66,388 | 14.97M |
| 460 | GRDX | GridAI Technologies Corp. | 28.61M | -0.49% | 303,233 | - |
| 461 | BYSI | BeyondSpring Inc. | 28.37M | -4.19% | 35,135 | 1.88M |
| 462 | CVM | CEL-SCI Corporation | 28.32M | 8.78% | 262,329 | - |
| 463 | LTRN | Lantern Pharma Inc. | 27.87M | - | 108,740 | - |
| 464 | EVAX | Evaxion A/S | 27.02M | -3.28% | 112,095 | 7.49M |
| 465 | NXTC | NextCure, Inc. | 26.69M | -1.35% | 90,097 | - |
| 466 | GNTA | Genenta Science S.p.A. | 26.66M | -1.74% | 41,660 | - |
| 467 | ENLV | Enlivex Ltd. | 26.49M | -0.33% | 147,878 | - |
| 468 | ATOS | Atossa Therapeutics, Inc. | 26.45M | -1.12% | 26,287 | - |
| 469 | QNTM | Quantum BioPharma Ltd. | 26.29M | -6.40% | 123,979 | - |
| 470 | CELU | Celularity Inc. | 25.48M | 9.94% | 175,883 | 26.55M |
| 471 | MRKR | Marker Therapeutics, Inc. | 24.18M | -4.61% | 33,826 | 3.55M |
| 472 | DYAI | Dyadic International, Inc. | 24.05M | -4.47% | 80,790 | 3.80M |
| 473 | CLRB | Cellectar Biosciences, Inc. | 24.01M | - | 13,189 | - |
| 474 | JSPR | Jasper Therapeutics, Inc. | 23.89M | -0.31% | 246,069 | - |
| 475 | TVRD | Tvardi Therapeutics, Inc. | 23.74M | -2.20% | 87,493 | - |
| 476 | NIKI | Niki BioSolutions, Inc. | 23.05M | -0.76% | 7,613 | - |
| 477 | CNSY | Cerenome, Inc. | 22.92M | -2.11% | 17,919 | 4.20M |
| 478 | LGVN | Longeveron Inc. | 22.42M | 3.43% | 650,309 | 1.19M |
| 479 | PLRZ | Polyrizon Ltd. | 21.83M | 6.97% | 41,648 | - |
| 480 | COCP | Cocrystal Pharma, Inc. | 21.57M | -0.88% | 18,774 | 330.00K |
| 481 | ALLR | Allarity Therapeutics, Inc. | 21.32M | 0.75% | 44,604 | 345.00K |
| 482 | NEUP | Neuphoria Therapeutics Inc. | 20.86M | - | 41,027 | -13.27K |
| 483 | CALC | CalciMedica, Inc. | 20.06M | -0.09% | 177,335 | - |
| 484 | PTN | Palatin Technologies, Inc. | 19.36M | 0.96% | 58,453 | 12.88M |
| 485 | CYCN | Cyclerion Therapeutics, Inc. | 19.12M | 3.75% | 91,263 | 1.90M |
| 486 | KTTA | Pasithea Therapeutics Corp. | 19.05M | 1.79% | 94,571 | - |
| 487 | CMMB | Chemomab Therapeutics Ltd. | 18.77M | 12.61% | 414,800 | - |
| 488 | ABVC | ABVC BioPharma, Inc. | 18.43M | -11.11% | 98,027 | 797.92K |
| 489 | LEXX | Lexaria Bioscience Corp. | 18.24M | -4.83% | 5,202 | 194.00K |
| 490 | NCEL | NewcelX Ltd. | 18.20M | -2.87% | 18,403 | - |
| 491 | BCDA | BioCardia, Inc. | 18.02M | 5.31% | 244,477 | 3.00K |
| 492 | LPCN | Lipocine Inc. | 17.73M | - | 106,046 | 1.57M |
| 493 | AKTX | Akari Therapeutics, Plc | 17.72M | 15.63% | 254,611 | - |
| 494 | TPST | Tempest Therapeutics, Inc. | 17.26M | -2.70% | 51,744 | - |
| 495 | PBM | Psyence Biomedical Ltd. | 16.48M | 1.17% | 41,202 | - |
| 496 | LSTA | Lisata Therapeutics, Inc. | 16.31M | 4.02% | 51,698 | 100.00K |
| 497 | PLUR | Pluri Inc. | 15.97M | -10.84% | 96,491 | 1.08M |
| 498 | BIVI | BioVie Inc. | 15.91M | 0.96% | 909,492 | - |
| 499 | CTXR | Citius Pharmaceuticals, Inc. | 15.84M | -4.41% | 442,406 | 7.11M |
| 500 | KALA | KALA BIO, Inc. | 15.78M | -0.60% | 10,836 | - |